Sharmila Banerjee Selected Research

Lutetium

4/2022	Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[177Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [177Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles.
7/2011	Lutetium DOTATATE whole body scans: A novel approach for evaluation of neuroendocrine tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharmila Banerjee Research Topics

Disease

41	Neoplasms (Cancer) 04/2022 - 02/2003
18	Pain (Aches) 10/2021 - 08/2002
16	Neoplasm Metastasis (Metastasis) 10/2021 - 08/2002
9	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2022 - 06/2011
8	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 10/2011
8	Fibrosarcoma 01/2018 - 02/2010
6	Breast Neoplasms (Breast Cancer) 06/2022 - 07/2005
5	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 05/2015
5	Hypoxia (Hypoxemia) 01/2016 - 07/2005
4	Carcinoma (Carcinomatosis) 10/2021 - 11/2006
3	Liver Neoplasms (Liver Cancer) 05/2009 - 07/2008
2	Infertility (Sterility) 01/2020 - 11/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 01/2017
2	Osteosarcoma (Osteogenic Sarcoma) 06/2017 - 01/2016
2	Melanoma (Melanoma, Malignant) 03/2017 - 06/2007
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 10/2010
2	Lymphoma (Lymphomas) 04/2011 - 02/2010
1	Ovarian Epithelial Carcinoma 06/2022
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Nausea 01/2021
1	Medullary Carcinoma 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019
1	Glioblastoma (Glioblastoma Multiforme) 05/2019
1	Glioma (Gliomas) 05/2019
1	Bone Neoplasms (Bone Cancer) 10/2018
1	Anaplastic Thyroid Carcinoma 09/2018
1	Cancer Pain 01/2017

Drug/Important Bio-Agent (IBA)

21	Radioisotopes (Radionuclides)IBA 04/2022 - 12/2004
17	RadiopharmaceuticalsIBA 10/2021 - 12/2004
11	Biological ProductsIBA 03/2017 - 12/2004
8	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 06/2022 - 08/2004
8	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 08/2004
7	Peptide Receptors (Peptide Receptor)IBA 04/2022 - 01/2016
6	AcidsIBA 06/2017 - 12/2004
6	PorphyrinsIBA 02/2015 - 02/2010
5	LigandsIBA 06/2022 - 05/2004
4	lutetium ethylenediaminetetramethylene phosphonic acidIBA 10/2021 - 03/2014
4	Durapatite (Hydroxylapatite)IBA 01/2016 - 07/2008
4	phosphonic acidIBA 12/2014 - 04/2008
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2022 - 08/2004
3	AntigensIBA 10/2021 - 01/2016
3	DOTA(0)-Tyr(3)-Thr(8)- 90Y-octreotateIBA 03/2021 - 09/2020
3	Thyroglobulin FDA Link 01/2021 - 05/2015
3	lutetium Lu 177 dotatateIBA 01/2021 - 01/2016
3	1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA 01/2018 - 12/2013
2	LutetiumIBA 04/2022 - 07/2011
2	177Lu-PSMA-617IBA 04/2021 - 12/2019
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2016
2	EndotoxinsIBA 01/2020 - 11/2014
2	Tumor Biomarkers (Tumor Markers)IBA 10/2019 - 01/2016
2	Organophosphonates (Phosphonates)IBA 01/2018 - 05/2004
2	Peptides (Polypeptides)IBA 01/2018 - 03/2013
2	IntegrinsIBA 03/2017 - 03/2013
2	AntibodiesIBA 01/2017 - 07/2005
2	177Lu- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid)IBA 12/2016 - 09/2008
2	MetalsIBA 01/2016 - 09/2008
2	MisonidazoleIBA 03/2015 - 03/2013
2	fluoromisonidazoleIBA 03/2015 - 08/2014
2	Colchicine FDA LinkGeneric 08/2014 - 02/2006
2	NitroimidazolesIBA 08/2014 - 07/2005
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2014 - 02/2006
2	iminodiacetic acidIBA 08/2014 - 12/2006
2	Androgen Receptors (Androgen Receptor)IBA 10/2011 - 11/2006
2	Estrogen ReceptorsIBA 07/2011 - 07/2005
2	Ethiodized Oil (Ethiodol)FDA Link 10/2010 - 05/2009
2	Metronidazole (Metric)FDA LinkGeneric 07/2005 - 02/2003
1	pertuzumabIBA 06/2022
1	Trastuzumab (Herceptin)FDA Link 06/2022
1	human ERBB2 proteinIBA 06/2022
1	Hormones (Hormone)IBA 10/2021
1	gallium 68 PSMA-11IBA 04/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Fibroins (Fibroin)IBA 12/2020
1	AndrogensIBA 01/2020
1	131I-rituximabIBA 12/2019
1	Monoclonal AntibodiesIBA 12/2019
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2019
1	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 05/2019
1	Androgen Antagonists (Antiandrogens)IBA 12/2018
1	jugloneIBA 09/2018
1	CatalaseIBA 09/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 09/2018
1	NGR peptideIBA 01/2018
1	asparagine-glycine-arginineIBA 01/2018
1	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2018
1	Etidronic Acid (HEDP)FDA LinkGeneric 06/2017
1	170Tm- ethylenediamine- tetramethylenephosphonic acidIBA 01/2017
1	tositumomab I-131 (Bexxar)FDA Link 01/2017
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017

Therapy/Procedure

29	Therapeutics 04/2022 - 08/2004
5	Palliative Care (Palliative Therapy) 01/2016 - 08/2002
4	Precision Medicine 03/2017 - 01/2016
4	Radiotherapy 04/2011 - 09/2008
3	Radioimmunotherapy 06/2022 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2006
2	Castration 04/2021 - 12/2018
1	Injections 01/2022
1	Orchiectomy (Orchidectomy) 10/2021
1	Secondary Prevention 01/2020